Adaptive Biotechnologies Corporation Common Stock (ADPT) Stock Price, Quote & AI Analysis
Live ADPT stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Adaptive Biotechnologies Corporation Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Adaptive Biotechnologies Corporation Common Stock (ADPT), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Adaptive Biotechnologies Corporation Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Adaptive Biotechnologies Corporation Common Stock Overview
Company information
Company Overview
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Adaptive Biotechnologies Corporation Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...